Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Duose DY"'
Autor:
Chauhan PS; Mayo Clinic, Rochester, MN, United States., Alahi I; Washington University in St. Louis, St. Louis, MO, United States., Sinha S; Washington University in St. Louis, St. Louis, MO, United States., Ledet EM; Tulane University, New Orleans, LA, United States., Mueller R; Washington University in St. Louis, ST. Louis, MO, United States., Linford J; Mayo Clinic, Rochester, MN, United States., Shiang AL; Cedars-Sinai Medical Center, United States., Webster J; Washington University in St. Louis, Saint Louis, MO, United States., Greiner L; Washington University in St. Louis, Saint Louis, MO, United States., Yang B; Washington University in St. Louis, Saint Louis, MO, United States., Ni G; Washington University in St. Louis, St. Louis, MO, United States., Dang HX; Washington University in St. Louis, St. Louis, United States., Saha D; Washington University in St. Louis, Saint Louis, MO, United States., Babbra RK; University of Rochester Medical Center, Rochester, New York, United States., Feng W; Washington University in St. Louis, St. Louis, MO, United States., Harris PK; Washington University in St. Louis, St. Louis, MO, United States., Qaium F; Washington University in St. Louis, Saint Louis, Missouri, United States., Duose DY; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sanchez-Espitia A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sherry AD; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jaeger EB; Tulane University, New Orleans, Louisiana, United States., Miller PJ; Ochsner Baptist Medical Center, New Orleans, LA, United States., Caputo SA; Tulane University, New Orleans, LA, United States., Orme JJ; Mayo Clinic, Rochester, MN, United States., Lucien F; Mayo Clinic, Rochester, MN, United States., Park SS; Mayo Clinic, Rochester, United States., Tang C; The University of Texas MD Anderson Cancer Center, Houston, tx, United States., Pachynski RK; Washington University in St. Louis, St. Louis, MO, United States., Sartor O; Mayo Clinic, Rochester, MN, United States., Maher CA; Washington University in St. Louis, St. Louis, MO, United States., Chaudhuri AA; Mayo Clinic, Rochester, MN, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Goltsov AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: agoltsov@mdanderson.org., Maru DM; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Katkhuda R; Department of Pathology, University of Chicago Medical Center, Chicago, Illinois., Duose DY; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Hematopathology-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Correa AM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang F; Computational Biology, The Janssen Pharmaceutical Companies of Johnson & Johnson, Shanghai, China., Futreal PA; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hofstetter WL; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
The Annals of thoracic surgery [Ann Thorac Surg] 2024 Jul; Vol. 118 (1), pp. 241-251. Date of Electronic Publication: 2023 Oct 06.
Autor:
Gonzalez-Kozlova E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Huang HH; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Jagede OA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tuballes K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Del Valle DM; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Patel M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Xie H; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Harris J; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Argueta K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Nie K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Barcessat V; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Moravec R; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Altreuter J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kahl BS; Washington University School of Medicine, New York, New York., Ansell SM; Mayo Clinic, New York, New York., Yu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Lindsay JR; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kim-Schulze S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Diefenbach CS; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Gnjatic S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1726-1737.
Autor:
Matin SF; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Adibi M; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Shah AY; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Alhalabi O; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Corn P; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Guo C; Department of Pathology, MD Anderson Cancer Center, Houston, Texas., Amirtharaj R; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Xiao L; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas., Lange S; Department of Urology, MD Anderson Cancer Center, Houston, Texas., Duose DY; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas., Wang S; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas., Pal S; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California., Campbell MT; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
The Journal of urology [J Urol] 2024 Jun; Vol. 211 (6), pp. 784-793. Date of Electronic Publication: 2024 Apr 04.
Autor:
Tan X; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Wang S; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Xiao GY; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Wu C; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Liu X; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Zhou B; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Yu J; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Duose DY; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Xi Y; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Wang J; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Gupta K; Department of Chemical Sciences, Tata Institute of Fundamental Research, Mumbai, India., Pataer A; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, United States of America., Roth JA; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, United States of America., Kim MP; Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America., Chen F; Department of Medicine and Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, United States of America., Creighton CJ; Department of Medicine and Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, United States of America., Russell WK; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, United States of America., Kurie JM; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Apr 25. Date of Electronic Publication: 2024 Apr 25.
Autor:
Parra ER; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Duose DY; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gonzalez-Kozlova E; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Redman MW; SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, Washington., Chen H; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Manyam GC; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kumar G; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazcano R; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Marques-Piubelli ML; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Laberiano-Fernandez C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rojas F; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang B; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taing L; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Jhaveri A; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Geisberg J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Altreuter J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Michor F; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Provencher J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Yu J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Cerami E; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Moravec R; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Kannan K; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alatrash G; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer, Houston, Texas., Huang HH; Precision Immunology Institute, Mount Sinai, New York, New York.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Xie H; Precision Immunology Institute, Mount Sinai, New York, New York., Patel M; Precision Immunology Institute, Mount Sinai, New York, New York., Nie K; Precision Immunology Institute, Mount Sinai, New York, New York., Harris J; Precision Immunology Institute, Mount Sinai, New York, New York., Argueta K; Precision Immunology Institute, Mount Sinai, New York, New York., Lindsay J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Biswas R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Nostrand S; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim-Schulze S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Gray JE; Moffitt Cancer Caner, Tampa, Florida., Herbst RS; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Wistuba II; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gettinger S; Moffitt Cancer Caner, Tampa, Florida., Kelly K; International Association for the Study of Lung Cancer, Denver, Colorado., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, California., Gnjatic S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haymaker C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 15; Vol. 30 (8), pp. 1655-1668.
Autor:
Zheng L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Alvarez HA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., San Lucas FA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fuller GN; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ballester LY; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sweeney KJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rashid A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yang RK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Liu A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Albarracin C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Routbort MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sahin AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ding Q; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 19; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 19.
Autor:
Stephen B; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hajjar J; Adult Allergy and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA., Sarda S; Thermo Fisher Scientific, Carlsbad, California, USA., Duose DY; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Conroy JM; OmniSeq Inc, Buffalo, New York, USA., Morrison C; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Alshawa A; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu M; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zarifa A; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SP; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kwiatkowski E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang L; Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodon Ahnert J; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fu S; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Meric-Bernstam F; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lowman GM; Thermo Fisher Scientific, Carlsbad, California, USA., Looney T; Thermo Fisher Scientific, Clinical Next-Generation Sequencing, Austin, Texas, USA., Naing A; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA anaing@mdanderson.org.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
Autor:
Lachowiez CA; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Loghavi S; The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas., Zeng Z; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Tanaka T; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Kim YJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Uryu H; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Turkalj S; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Jakobsen NA; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Luskin MR; Dana-Farber Cancer Institute, Leukemia Program, Boston, Massachusetts., Duose DY; The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, Texas., Tidwell RSS; The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, Texas., Short NJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Borthakur G; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Kadia TM; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Masarova L; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Tippett GD; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Bose P; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Jabbour EJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Ravandi F; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Daver NG; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Kantarjian H; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Garcia JS; Dana-Farber Cancer Institute, Leukemia Program, Boston, Massachusetts., Vyas P; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Takahashi K; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., Konopleva M; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas., DiNardo CD; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, Texas.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2023 Jul 05; Vol. 4 (4), pp. 276-293.
Autor:
Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org., Msaouel P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PMsaouel@mdanderson.org.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Marmonti E; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Soto LMS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Laberiano-Fernandez C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lozano M; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Abraham A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hallin M; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Chin CD; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Olson P, Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Yan X; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wood CG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 May 10; Vol. 14 (1), pp. 2684. Date of Electronic Publication: 2023 May 10.